The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the state register of medicines formedical application of the medicinal product (registration certificate P N015668 / 01 dated 10.06.2009 issued by Pharmaceutical Industry Serono SpA, Italy):
Ovitrel® (trade name of the medicinal product)
Choriogonadotropin alfa (international non-proprietary or batch or chemical name)
lyophilizate for the preparation of a solution for subcutaneous administration, 250 μg (dosage form, dosage)
Industry Pharmaceuticals Serono SpA, Italy Via de Blasio, Zona Industriale di Modugno, 1-70123 Bari, Italy (name and address of the location of the manufacturer of the medicinal product)
on the basis of filing by the authorized legal entity LLC Merck, Russia of a request for the cancellation of the state registration of a medicinal product.